[go: up one dir, main page]

IT1298492B1 - USE OF BETA3-ADRENERGIC AGONIST COMPOUNDS FOR THE PREPARATION OF DRUGS CAPABLE OF INDURING THE RELEASE OF THE "GLP-1" HORMONE - Google Patents

USE OF BETA3-ADRENERGIC AGONIST COMPOUNDS FOR THE PREPARATION OF DRUGS CAPABLE OF INDURING THE RELEASE OF THE "GLP-1" HORMONE

Info

Publication number
IT1298492B1
IT1298492B1 IT96TO000284A ITTO960284A IT1298492B1 IT 1298492 B1 IT1298492 B1 IT 1298492B1 IT 96TO000284 A IT96TO000284 A IT 96TO000284A IT TO960284 A ITTO960284 A IT TO960284A IT 1298492 B1 IT1298492 B1 IT 1298492B1
Authority
IT
Italy
Prior art keywords
induring
beta3
glp
hormone
release
Prior art date
Application number
IT96TO000284A
Other languages
Italian (it)
Inventor
Cyril Jacques Bouloux
Luciano Manara
Stephen Robert Bloom
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9504448A external-priority patent/FR2732894B1/en
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of ITTO960284A0 publication Critical patent/ITTO960284A0/it
Publication of ITTO960284A1 publication Critical patent/ITTO960284A1/en
Application granted granted Critical
Publication of IT1298492B1 publication Critical patent/IT1298492B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT96TO000284A 1995-04-13 1996-04-12 USE OF BETA3-ADRENERGIC AGONIST COMPOUNDS FOR THE PREPARATION OF DRUGS CAPABLE OF INDURING THE RELEASE OF THE "GLP-1" HORMONE IT1298492B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9504448A FR2732894B1 (en) 1995-04-13 1995-04-13 NEW USE OF BETA9-ADRENERGIC AGONIST COMPOUNDS
FR9512694A FR2734482B1 (en) 1995-04-13 1995-10-27 NEW USE OF BETA3-ADRENERGIC AGONIST COMPOUNDS

Publications (3)

Publication Number Publication Date
ITTO960284A0 ITTO960284A0 (en) 1996-04-12
ITTO960284A1 ITTO960284A1 (en) 1997-10-12
IT1298492B1 true IT1298492B1 (en) 2000-01-10

Family

ID=26231888

Family Applications (1)

Application Number Title Priority Date Filing Date
IT96TO000284A IT1298492B1 (en) 1995-04-13 1996-04-12 USE OF BETA3-ADRENERGIC AGONIST COMPOUNDS FOR THE PREPARATION OF DRUGS CAPABLE OF INDURING THE RELEASE OF THE "GLP-1" HORMONE

Country Status (3)

Country Link
BE (1) BE1009698A3 (en)
FR (1) FR2734482B1 (en)
IT (1) IT1298492B1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5106867A (en) * 1990-05-04 1992-04-21 American Cyanamid Company Method of increasing lean meat in edible animals
US5061727A (en) * 1990-05-04 1991-10-29 American Cyanamid Company Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
JPH06345731A (en) * 1992-04-28 1994-12-20 Dainippon Pharmaceut Co Ltd 2- [2- (Indol-3-yl) ethylamino] -1-phenylethanol derivative

Also Published As

Publication number Publication date
ITTO960284A1 (en) 1997-10-12
FR2734482B1 (en) 1997-08-14
BE1009698A3 (en) 1997-07-01
FR2734482A1 (en) 1996-11-29
ITTO960284A0 (en) 1996-04-12

Similar Documents

Publication Publication Date Title
IT1240360B (en) USE OF AN ALPHA-HYDROXIVITAMIN D DERIVATIVE FOR THE PREPARATION OF A MEDICATION FOR THE TREATMENT OF HYPERPARATIROIDISM
ZA98691B (en) Use of central cannabinoid receptor antagonists for the preparation of drugs
NO20073430L (en) Use of an antibody against interleukin-6 receptor for the preparation of a pharmaceutical composition
BR9602705A (en) Compound pharmaceutical composition process for the preparation of a compound and use
AU4396193A (en) 3-benzylamino-2-phenyl-piperidine derivatives as substance p receptor antagonists
ATE219377T1 (en) NEW GALENIC ORAL PHARMACEUTICAL FORMULATION
HUP0100266A3 (en) 1-amino-alkylcyclohexane nmda receptor antagonists, pharmaceutical compositions containing the compounds and their preparations
NO20041007L (en) Use of oxypurine nucleosides for the preparation of a pharmaceutical composition
ITMI912025A0 (en) PROCEDURE FOR THE PREPARATION OF DEMETHYLEPIPODOPHYLLOTOXIN-BETA-DGLUCOSIDES
IT9019112A1 (en) PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR THE ORAL ADMINISTRATION OF CALCITONIN
HUP0100171A3 (en) Use of endothelin receptor antagonists for producing pharmaceutical preparations for combating obesity
MX14533A (en) PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL COMPOUNDS
HUP9600517A3 (en) New tricyclic derivatives, their preparation, their use for the preparation of optically active or valemic colchicine and thiocolchine and analogues and derivatives and intermediates
BR9812404A (en) Combination of an endothelin antagonist, pharmaceutical preparation, process for preparing a pharmaceutical preparation, and use of a combination of a beta receptor blocker and an endothelin antagonist
IT1298492B1 (en) USE OF BETA3-ADRENERGIC AGONIST COMPOUNDS FOR THE PREPARATION OF DRUGS CAPABLE OF INDURING THE RELEASE OF THE "GLP-1" HORMONE
ITMI951649A0 (en) USE OF COMPOUNDS AGONISTS OR ANTAGONISTS OF PURINE P2 RECEPTORS FOR THE PREVENTION OF GLUTAMATE CYTOTOXICITY
AU2836495A (en) Use of neurotensin antagonists for the preparation of diuretic drugs
ZA98484B (en) Use of beta3-adrenergic receptor agonists for the preparation of healing drugs
IT1296495B1 (en) USE OF BISPHOSPHONATES IN THE PREPARATION OF PHARMACEUTICAL FORMS FOR INTRAMUSCULAR ADMINISTRATION
IT1280428B1 (en) PHARMACEUTICAL COMPOSITION FOR TOPICAL USE
IT9020943A0 (en) PHARMACEUTICAL COMPOSITION FOR ORAL USE WITH MODIFIED RELEASE OF NON-STEROID ANTI-INFLAMMATORS
IT1215325B (en) -H2 RECEPTOR ANTAGONIST COMPOUNDS AND PROCEDURE FOR THEIR PREPARATION.
ITMI931371A1 (en) PROCEDURE FOR THE PREPARATION OF ERDOSTEIN
IT1275457B (en) USE OF ENDORPHINE SEQUENCES FOR THE PREPARATION OF AN IMMUNOSUPPRESSOR DRUG WITHOUT OPPIACEA ACTIVITY
ITMI931049A1 (en) MUCOADHESIVE PHARMACEUTICAL COMPOSITION WITH CONTROLLED RELEASE FOR THE ORAL ADMINISTRATION OF FUROSEMIDE

Legal Events

Date Code Title Description
0001 Granted